profit from every $100 of sales.
$0$100
Alpha Tau Medical
$2.77-9.78% today
+693.7% in 1 year
1-year low $0.281-year high $4.37
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Alpha Tau Medical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$42.6 million of profit last year.
SalesProfit
Alpha Tau Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Alpha Tau Medical | No profit yet | ||
 Vertex Pharmaceuticals | 34.8× · Expensive | ||
 Regeneron Pharmaceuticals | 21.8× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.3× · Fair price |
AI analysis
An AI analyst reads Alpha Tau Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -32 | -36 | -36 | -42 | |
| -33 | -28 | -30 | -41 | |
| -34 | -29 | -32 | -43 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 120 | 107 | 86 | 106 |
| Cash | 6 | 13 | 14 | 12 |
| Total debt | 5 | 13 | 13 | 14 |
| Total liabilities | 14 | 23 | 24 | 29 |
| 106 | 84 | 63 | 77 | |
| – | – | – | – | |
| -24.0% | -23.5% | -33.0% | -36.7% | |
| -32.0% | -34.5% | -50.7% | -55.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -24 | -18 | -20 | -27 | |
| 1 | 6 | 2 | 6 | |
| -25 | -24 | -22 | -33 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 7 | 8 | 10 | 11 |
Valuation
- –
- –
- 1.49
- 11.5×
- 0.0×
- –
- –
- -17.3%
- -4.8%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- 17.6%
- -58.3%
- -57.3%
- -40.0%
- 17.8%
- –
Growth
- –
- –
- −48.7%
- –
- +18.7%
Financial health
- 0.1×
- 0.18
- 12.9%
- –
- 7.45
- 7.45
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 12%of 952
Bottom 20%of 883
Bottom 5%of 985
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 18, 2026 | -0.26 | -0.12 | −110.4% |
| Mar 9, 2026 | -0.14 | -0.12 | −15.7% |
| Aug 11, 2025 | -0.13 | -0.11 | −13.6% |
| May 19, 2025 | -0.12 | -0.12 | +2.1% |
| Dec 31, 2023 | -0.11 | – | – |
News
Alpha and Omega Semiconductor surges over 20% for second consecutive sessionSeeking Alpha · Nov 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
41No pass
Philip Fisher
34No pass
Peter Lynch
59No pass
Joel Greenblatt
21No pass
Charlie Munger
33No pass
Terry Smith
29No pass
Questions about Alpha Tau Medical
Is Alpha Tau Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Alpha Tau Medical AI analysis
What does Alpha Tau Medical do?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. It is in Biotechnology.
Does Alpha Tau Medical pay a dividend?
No. Alpha Tau Medical does not pay a dividend at the moment.
How has Alpha Tau Medical stock done over the past year?
Up 693.7% over the past twelve months, to $2.77. It traded between $0.28 and $4.37 and is 36.6% below its high.
Who are Alpha Tau Medical's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Alpha Tau Medical's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.